PCR262 Real-World Outcomes and Health Care Resource Utilization of Onasemnogene Abeparvovec for US Patients With Spinal Muscular Atrophy Type 2: Results of a Retrospective Chart Review Study
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.2195
https://www.valueinhealthjournal.com/article/S1098-3015(22)04400-X/fulltext
Section Title :
Section Order :
11756
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04400-X&doi=10.1016/j.jval.2022.09.2195